Holen Sie sich die Stockscreener-App
15.60
0.32%
0.05
Handel nachbörslich:
15.60
Denali Therapeutics Inc Aktie (DNLI) Neueste Nachrichten
What to do if you’re stuck in Denali Therapeutics Inc.New Guidance & Verified Momentum Stock Watchlist - Newser
Market reaction to Denali Therapeutics Inc.’s recent newsTrade Analysis Summary & Safe Entry Point Identification - Newser
Momentum divergence signals in Denali Therapeutics Inc. chartLayoff News & Daily Growth Stock Investment Tips - Newser
What technical models suggest about Denali Therapeutics Inc.’s comebackCEO Change & Smart Swing Trading Alerts - Newser
Chart based analysis of Denali Therapeutics Inc. trends2025 Market Sentiment & Fast Moving Market Watchlists - Newser
News impact scoring models applied to Denali Therapeutics Inc.July 2025 Snapshot & Smart Allocation Stock Tips - Newser
Heatmap analysis for Denali Therapeutics Inc. and competitorsMarket Sentiment Summary & Daily Price Action Insights - Newser
Real time breakdown of Denali Therapeutics Inc. stock performanceWeekly Profit Summary & Long Hold Capital Preservation Tips - Newser
Using data filters to optimize entry into Denali Therapeutics Inc.2025 Trading Recap & Free Long-Term Investment Growth Plans - Newser
Price action breakdown for Denali Therapeutics Inc.Weekly Stock Recap & Real-Time Volume Analysis - Newser
How to recover losses in Denali Therapeutics Inc. stockSwing Trade & Trade Opportunity Analysis - Newser
Can technical indicators confirm Denali Therapeutics Inc.’s reversal2025 Breakouts & Breakdowns & Precise Buy Zone Tips - Newser
Denali Therapeutics Inc. stock retracement – recovery analysisJuly 2025 Recap & Fast Gain Swing Alerts - Newser
What MACD signals say about Denali Therapeutics Inc.July 2025 Price Swings & Accurate Intraday Trading Signals - Newser
Will Denali Therapeutics Inc. stock go up soon2025 Risk Factors & Weekly Hot Stock Watchlists - Newser
Flagship Pioneering Launches Metaphore Biotechnologies to Unlock the Therapeutic Potential of Biomimicry - Quantisnow
How cyclical is Denali Therapeutics Inc.’s revenue stream2025 Macro Impact & Verified Entry Point Detection - theviewers.co.kr
How to interpret RSI for Denali Therapeutics Inc. stockWeekly Stock Analysis & Daily Stock Trend Reports - Newser
What’s the analyst consensus on Denali Therapeutics Inc.2025 Market Trends & AI Driven Price Forecasts - sundaytimes.kr
Is Denali Therapeutics Inc.’s growth already priced in2025 Dividend Review & Real-Time Chart Breakout Alerts - theviewers.co.kr
Alltrna Appoints Caroline Kӧhrer, Ph.D., Vice President, Discovery Platform - Quantisnow
Denali Therapeutics Inc. (DNLI) Secures FDA Priority Review for First-Ever Brain-Penetrant Hunter Syndrome Therapy - MSN
Can Denali Therapeutics Inc. Regain Lost Ground This Quarter2025 Price Targets & Smart Swing Trading Alerts - newsyoung.net
Morgan Stanley Keeps Overweight Rating on Denali, PT Down to $30 - AInvest
Technical signs of recovery in Denali Therapeutics Inc.2025 Top Decliners & Consistent Return Investment Signals - Newser
What makes Denali Therapeutics Inc. stock price move sharplyJuly 2025 Intraday Action & Free Fast Gain Swing Trade Alerts - Newser
Intraday pattern recognizer results for Denali Therapeutics Inc.July 2025 Sector Moves & Stepwise Entry/Exit Trade Alerts - Newser
Is now a turning point for Denali Therapeutics Inc.2025 Earnings Surprises & Fast Momentum Entry Tips - Newser
Can Denali Therapeutics Inc. be the next market leaderEarnings Risk Report & Safe Capital Growth Tips - thegnnews.com
Sentiment analysis tools applied to Denali Therapeutics Inc.Quarterly Performance Summary & Weekly Watchlist for Consistent Profits - Newser
Is Denali Therapeutics Inc. stock technically oversold2025 EndofYear Setup & Low Drawdown Trading Techniques - sundaytimes.kr
Is Denali Therapeutics Inc. Stock a Good Fit for Conservative InvestorsCPI Data & Fast Moving Trade Plans - Newser
BTIG Reiterates a Buy Rating on Denali Therapeutics (DNLI) With a $32 Price Target - MSN
Denali Therapeutics Inc. Earnings Report Breakdown: What Investors Should Know2025 Major Catalysts & Weekly Chart Analysis and Trade Guides - Newser
Why Denali Therapeutics Shares Are Slipping - TipRanks
Is Denali Therapeutics Inc. subject to activist investor interestTrade Volume Report & AI Optimized Trade Strategies - thegnnews.com
Denali Therapeutics Inc. Stock Approaches Key Moving Average2025 Valuation Update & Community Verified Swing Trade Signals - sundaytimes.kr
Denali Therapeutics COFO Schuth sells $39884 in stock By Investing.com - Investing.com Canada
DNLI Tops on Q2 Earnings, Expects Decree on Hunter Syndrome Drug in '26 - MSN
Denali therapeutics’ Ho Carole sells $52k in stock - Investing.com
Denali Therapeutics COFO Schuth sells $39884 in stock - Investing.com
Science Spotlight: How Denali’s CNS-penetrant amyloid mAb may avoid ARIA - biocentury.com
XTX Topco Ltd Lowers Stock Holdings in Denali Therapeutics Inc. (NASDAQ:DNLI) - Defense World
Elliott Wave Theory Predicts Pullback in Denali Therapeutics Inc.July 2025 Reactions & Community Consensus Picks - beatles.ru
Earnings visualization tools for Denali Therapeutics Inc.Weekly Profit Summary & Weekly Momentum Picks - Newser
Denali Soars 11% on Biotech Sector Turmoil: What’s Fueling This Surge? - AInvest
0.98%
8.06%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):